160 related articles for article (PubMed ID: 8772717)
1. The hsp60 peptide p277 arrests the autoimmune diabetes induced by the toxin streptozotocin.
Elias D; Cohen IR
Diabetes; 1996 Sep; 45(9):1168-72. PubMed ID: 8772717
[TBL] [Abstract][Full Text] [Related]
2. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
Bockova J; Elias D; Cohen IR
J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
[TBL] [Abstract][Full Text] [Related]
3. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens.
Elias D; Meilin A; Ablamunits V; Birk OS; Carmi P; Könen-Waisman S; Cohen IR
Diabetes; 1997 May; 46(5):758-64. PubMed ID: 9133541
[TBL] [Abstract][Full Text] [Related]
4. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
[TBL] [Abstract][Full Text] [Related]
5. NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells.
Birk OS; Elias D; Weiss AS; Rosen A; van-der Zee R; Walker MD; Cohen IR
J Autoimmun; 1996 Apr; 9(2):159-66. PubMed ID: 8738959
[TBL] [Abstract][Full Text] [Related]
6. Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity.
Quintana FJ; Rotem A; Carmi P; Cohen IR
J Immunol; 2000 Dec; 165(11):6148-55. PubMed ID: 11086048
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein 60 peptide p277.
Elias D; Cohen IR
Diabetes; 1995 Sep; 44(9):1132-8. PubMed ID: 7657040
[TBL] [Abstract][Full Text] [Related]
8. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice.
Szebeni A; Prohászka Z; Buzás E; Falus A; Kecskeméti V
Inflamm Res; 2008 Apr; 57(4):178-82. PubMed ID: 18351435
[TBL] [Abstract][Full Text] [Related]
9. Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide.
Elias D; Tikochinski Y; Frankel G; Cohen IR
Int Immunol; 1999 Jun; 11(6):957-66. PubMed ID: 10360970
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin.
Elias D; Prigozin H; Polak N; Rapoport M; Lohse AW; Cohen IR
Diabetes; 1994 Aug; 43(8):992-8. PubMed ID: 8039607
[TBL] [Abstract][Full Text] [Related]
11. A rationally designed peptide IA-2-P2 against type 1 diabetes in streptozotocin-induced diabetic mice.
Shen L; Lu S; Huang D; Li G; Liu K; Cao R; Zong L; Jin L; Wu J
Diab Vasc Dis Res; 2017 May; 14(3):184-190. PubMed ID: 28467202
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of non-obese diabetic mice with a fragment of peptide P277 attenuates insulin-dependent diabetes mellitus.
Ma YJ; Lu Y; Hou J; Dong YK; Du MZ; Xing Y; Ge CY; Xu ML; Jin L; Cao RY; Li TM; Wu J; Liu JJ
Int Immunopharmacol; 2011 Sep; 11(9):1298-302. PubMed ID: 21530685
[TBL] [Abstract][Full Text] [Related]
13. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
Ablamunits V; Elias D; Reshef T; Cohen IR
J Autoimmun; 1998 Feb; 11(1):73-81. PubMed ID: 9480725
[TBL] [Abstract][Full Text] [Related]
14. Novel mutant P277 peptide VP to ameliorate atherogenic side-effects and to preserve anti-diabetic effects in NOD mice.
Zhang Y; Lu S; Alahdal M; Gao H; Shen Y; Pan Y; Wu J; Xing Y; Jin L
Exp Cell Res; 2018 Oct; 371(2):399-408. PubMed ID: 30179603
[TBL] [Abstract][Full Text] [Related]
15. A Th1-recognized peptide P277, when tandemly repeated, enhances a Th2 immune response toward effective vaccines against autoimmune diabetes in nonobese diabetic mice.
Jin L; Zhu A; Wang Y; Chen Q; Xiong Q; Li J; Sun Y; Li T; Cao R; Wu J; Liu J
J Immunol; 2008 Jan; 180(1):58-63. PubMed ID: 18097004
[TBL] [Abstract][Full Text] [Related]
16. A novel multi-epitope vaccine based on Dipeptidyl Peptidase 4 prevents streptozotocin-induced diabetes by producing anti-DPP4 antibody and immunomodulatory effect in C57BL/6J mice.
Li Z; Fang J; Jiao R; Wei X; Ma Y; Liu X; Cheng P; Li T
Biomed Pharmacother; 2017 May; 89():1467-1475. PubMed ID: 28376584
[TBL] [Abstract][Full Text] [Related]
17. Enhanced immunogenicity of peptide P277 by heat shock protein HSP65 vector carrying tandem repeats of P277 to prevent type 1 diabetes in NOD mice.
Liang J; Aihua Z; Yu W; Jingjing L
Exp Clin Endocrinol Diabetes; 2008 Oct; 116(9):541-8. PubMed ID: 18473288
[TBL] [Abstract][Full Text] [Related]
18. Effect of intrathymic administration of mycobacterial heat shock protein 65 and peptide p277 on the development of diabetes in NOD mice: caution required in vaccination studies.
Funda DP; Hartoft-Nielsen ML; Kaas A; Buschard K
APMIS; 1998 Oct; 106(10):1009-16. PubMed ID: 9833705
[TBL] [Abstract][Full Text] [Related]
19. Peptide therapy for diabetes in NOD mice.
Elias D; Cohen IR
Lancet; 1994 Mar; 343(8899):704-6. PubMed ID: 7907681
[TBL] [Abstract][Full Text] [Related]
20. HSP65 serves as an immunogenic carrier for a diabetogenic peptide P277 inducing anti-inflammatory immune response in NOD mice by nasal administration.
Liang J; Aihua Z; Yu W; Yong L; Jingjing L
Vaccine; 2010 Apr; 28(19):3312-7. PubMed ID: 20226247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
